Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniela Wenge, M.D., M.D.

Concepts (43)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Daniela Wenge's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Daniela Wenge has written about over time.
Antibodies, Bispecific, 1 publications between 2020 and 2020, average publication date June 2020. Hematopoietic Stem Cell Transplantation, 2 publications between 2020 and 2021, average publication date October 2020. Transplantation, Homologous, 2 publications between 2020 and 2021, average publication date October 2020. Disease-Free Survival, 1 publications between 2021 and 2021, average publication date March 2021. Hodgkin Disease, 1 publications between 2021 and 2021, average publication date March 2021. Stem Cell Transplantation, 1 publications between 2021 and 2021, average publication date March 2021. Transplantation Conditioning, 1 publications between 2021 and 2021, average publication date March 2021. Leukemia, 2 publications between 2023 and 2023, average publication date July 2023. Mutation, 4 publications between 2023 and 2024, average publication date October 2023. Proteomics, 1 publications between 2023 and 2023, average publication date December 2023. Proto-Oncogene Proteins, 2 publications between 2023 and 2024, average publication date December 2023. Myeloid-Lymphoid Leukemia Protein, 4 publications between 2023 and 2024, average publication date March 2024. Morpholines, 1 publications between 2024 and 2024, average publication date April 2024. Phthalimides, 1 publications between 2024 and 2024, average publication date April 2024. Piperidones, 1 publications between 2024 and 2024, average publication date April 2024. Histone-Lysine N-Methyltransferase, 2 publications between 2023 and 2024, average publication date April 2024. Leukemia, Myeloid, Acute, 3 publications between 2023 and 2024, average publication date April 2024. Nuclear Proteins, 1 publications between 2024 and 2024, average publication date September 2024.

To see the data from this visualization as text, click here.
Wenge's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (43)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.